Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAX8 | Q06710 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7089370 | 1.00 | PAX8 (0.31) | PAX8 | |
| SCHEMBL11587168 | 1.00 | PAX8 (0.31) | PAX8 | |
| SCHEMBL11372719 | 1.00 | PAX8 (0.31) | PAX8 | |
| SCHEMBL11375580 | 1.00 | PAX8 (0.31) | PAX8 | |
| SCHEMBL7148697 | 1.00 | PAX8 (0.31) | PAX8 | |
| SCHEMBL272883 | 1.00 | PAX8 (0.31) | PAX8 | |
| SCHEMBL8528219 | 1.00 | PAX8 (0.31) | PAX8 | |
| Hydrochloric Acid SCHEMBL11424213 | 0.98 | PAX8 (0.30) | PAX8 | |
| SCHEMBL30685396 | 0.81 | — | — | |
| SCHEMBL4001228 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 656 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9200026-B2 | Antibacterial agents | MERCK SHARP & DOHME CORP. (US) | 2015-12-01 | — | — | US | claimed |
| US-20140073589-A1 | Amphetamine Prodrugs | SHIRE AG (CH) | 2014-03-13 | — | — | US | claimed |
| WO-2014002039-A1 | AMPHETAMINE PRODRUGS | SHIRE AG (CH) | 2014-01-03 | — | — | WO | claimed |
| EP-1628986-B1 | SYNTHESIS OF HIGH MOLECULAR WEIGHT IRON-SACCHARIDIC COMPLEXES | CHROMACEUTICAL ADVANCED TECH (US) | 2013-04-24 | — | — | EP | claimed |
| US-7964568-B2 | Controlling temperature and pH while complexing | CHROMACEUTICAL ADVANCED TECHNOLOGIES, INC. (US) | 2011-06-21 | — | — | US | claimed |
| US-7538092-B2 | Pharmaceutically active oligosaccharide conjugates | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2009-05-26 | — | — | US | claimed |
| EP-1549350-B1 | PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES | FRESENIUS KABI DE GMBH (DE) | 2008-09-24 | — | — | EP | claimed |
| CN-1798754-A | Synthesis of high molecular weight iron-saccharidic complexes | CHROMACEUTICAL ADVANCED TECH (US) | 2006-07-05 | — | — | CN | claimed |
| US-20060100163-A1 | Pharmaceutically active oligosaccharide conjugates | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2006-05-11 | — | — | US | claimed |
| EP-1628986-A2 | SYNTHESIS OF HIGH MOLECULAR WEIGHT IRON-SACCHARIDIC COMPLEXES | Chromaceutical Advanced Technologies, Inc. (US) | 2006-03-01 | — | — | EP | claimed |
| US-6150325-A | FOR TREATMENT OF ARTHRITIS, ASTHMA, INFLAMMATIONS, TUMORAL GROWTH, GASTROINTESTINAL HYPERMOTILITY, HUNTINGTON'S DISEASE, NEURITIS, NEURALGIA, HEMICRANIA, HYPERTENSION, URINARY INCONTINENCE, URTICARIA | A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. (IT) | 2000-11-21 | — | — | US | claimed |
| EP-0971716-A1 | BIS-ANTHRACYCLINES WITH HIGH ACTIVITY AGAINST DOXORUBICIN RESISTANT TUMORS | Priebe, Waldemar (US) | 2000-01-19 | — | — | EP | claimed |
| EP-0971716-A4 | BIS-ANTHRACYCLINES WITH HIGH ACTIVITY AGAINST DOXORUBICIN RESISTANT TUMORS | PRIEBE WALDEMAR (US) | 2000-01-19 | — | — | EP | claimed |
| WO-1999058543-A1 | NEW N-ALKYLOXYCARBONYL DERIVATIVES OF MONOSACCHARIDES L-ACOSAMINE AND L-DAUNOSAMINE | INSTYTUT FARMACEUTYCZNY (PL) | 1999-11-18 | — | — | WO | claimed |
| US-5874412-A | ANTICANCER AGENTS | PRIEBE WALDEMAR (US) | 1999-02-23 | — | — | US | claimed |
| CN-1183786-A | Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition | MENARINI FARMA IND (IT) | 1998-06-03 | — | — | CN | claimed |
| EP-0815126-A1 | BICYCLIC TACHYKININS ANTAGONISTS, PREPARATION THEREOF AND THEIR USE IN PHARMACEUTICAL COMPOSITION | A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. (IT) | 1998-01-07 | — | — | EP | claimed |
| WO-1997034612-A1 | BIS-ANTHRACYCLINES WITH HIGH ACTIVITY AGAINST DOXORUBICIN RESISTANT TUMORS | PRIEBE WALDEMAR (US) | 1997-09-25 | — | — | WO | claimed |
| WO-1996028467-A1 | BICYCLIC TACHYKININS ANTAGONISTS, PREPARATION THEREOF AND THEIR USE IN PHARMACEUTICAL COMPOSITION | A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. (IT) | 1996-09-19 | — | — | WO | claimed |
| WO-1995012588-A1 | ANTINEOPLASTIC HETERONAPHTHOQUINONES | BIOCHEM PHARMA INC. (CA) | 1995-05-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140073589-A1 | Amphetamine Prodrugs | SLC6A2, SLC6A3, TAAR5 | PAX8 3868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.